Revolut, Europe’s most valuable startup, has informed its staff of an upcoming sale of up to $500 million worth of existing shares. The sale, which values the company at $45 billion, will allow eligible employees to sell a portion of their vested share options. This move marks a significant milestone for Revolut, reinforcing its position… Continue reading Revolut announces $45 billion share sale to staff
stocktrader
Is Nvidia in a ‘bubble’? Hedge fund Elliott raises concerns over AI investments
Elliott Management, a Florida-based hedge fund managing approximately $70 billion in assets, has issued a stark warning to its investors regarding Nvidia, asserting that the chipmaking giant’s stock is caught in a “bubble” driven by exaggerated expectations surrounding artificial intelligence (AI). The firm conveyed this message in a recent letter to clients, a copy of… Continue reading Is Nvidia in a ‘bubble’? Hedge fund Elliott raises concerns over AI investments
Why did VSee Health (VSEE) stock surge more than 200% today?
VSee Health Inc (NASDAQ: VSEE) saw its stock nearly triple on Friday, fueled by an exciting new partnership with Ava Robotics. This collaboration aims to enhance intensive care units (ICUs) by integrating VSee’s telehealth technology into Ava’s robotic systems, allowing for remote, personalized patient care. The newly announced partnership will see VSee’s software embedded into… Continue reading Why did VSee Health (VSEE) stock surge more than 200% today?
Exxon soars in Q2 earnings, Chevron slumps: What investors should know
ExxonMobil and Chevron, the largest oil and gas companies in the US by market capitalization, reported their Q2 earnings on Friday, highlighting divergent strategies and outcomes in a challenging market. While both companies faced pressure from declining refining margins, Exxon managed to weather the storm more effectively than Chevron, showcasing its robust strategic adjustments and… Continue reading Exxon soars in Q2 earnings, Chevron slumps: What investors should know
Strategist warns on Intel’s AI prospects as stock plunges 20% amid job cuts and dividend suspension
Intel Corp (NASDAQ: INTC) has been striving to establish itself as a significant player in the artificial intelligence (AI) sector. However, Eric Ross, Chief Investment Strategist at Cascend Securities, warns that Intel is not truly an AI stock. Ross criticizes Intel for lagging in process technology advancements over the past decade, which has contributed to… Continue reading Strategist warns on Intel’s AI prospects as stock plunges 20% amid job cuts and dividend suspension
UN food price index dips slightly in July
The United Nations Food and Agriculture Organization (FAO) released its latest data on Friday, indicating a slight dip in the global food price index for July. The index, which monitors the prices of the most internationally traded food commodities, fell to 120.8 points, down from a revised 121.0 in June. This slight decrease marks a… Continue reading UN food price index dips slightly in July
US stocks tumble amid weak economic data: What went wrong?
US stocks faced significant selling pressure Thursday afternoon, driven by disappointing economic data and a sharp decline in chip stocks. This led to losses across all three major indexes, following the Federal Reserve’s indication of a likely rate cut in September. The S&P 500 declined nearly 1.5%, and the Nasdaq Composite reversed its earlier gains,… Continue reading US stocks tumble amid weak economic data: What went wrong?
CleanSpark expands in Wyoming, overtakes Riot as second-largest Bitcoin miner in US
CleanSpark, the Nasdaq-listed Bitcoin miner, has announced significant expansions to its mining operations with groundbreaking facilities in Wyoming. This move positions CleanSpark as the second-largest Bitcoin miner in the United States by market cap, surpassing Riot Platforms whose stock has retreated for nine straight days although analysts at H.C Wainwrite are bullish on it. Marathon… Continue reading CleanSpark expands in Wyoming, overtakes Riot as second-largest Bitcoin miner in US
Eli Lilly’s tirzepatide injection results could trigger another bull run: Here’s why
Eli Lilly and Company (NYSE: LLY) recently announced promising results from its SUMMIT phase 3 trials, focusing on the efficacy of the tirzepatide injection. The positive findings have sparked investor interest, driving the stock up by 3% today. These results are not only significant for Eli Lilly but also hold potential for millions of patients… Continue reading Eli Lilly’s tirzepatide injection results could trigger another bull run: Here’s why